Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO) / European Reference Network on Rare Adult Solid Cancers (EURACAN)

The CPG provides key recommendations and algorithms for managing SMs, excluding mucosal melanoma and soft-tissue sarcomas

The guideline covers diagnosis, staging, risk assessment, treatment and disease monitoring.

Technological advancements in treatment with RT are discussed with a special focus on particle therapy.

Surgical indications for open and transnasal endoscopic surgery are provided.

Neoadjuvant chemotherapy in high-grade, locally advanced SMs helps to select subjects for conservative treatments.


Read full Guideline